|
Anthem Biosciences Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
34645.72 Cr.
|
P/BV
|
12.59
|
Book Value (Rs.)
|
49.01
|
|
52 Week High/Low (Rs.)
|
874/604
|
FV/ML
|
2/1
|
P/E(X)
|
76.78
|
|
Bookclosure
|
|
EPS (Rs.)
|
8.04
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 1090.24 | 981.00 | 863.55 |
| Total Income From Operations | 1090.24 | 981.00 | 863.55 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 363.47 | 438.69 | 391.93 |
| Increase/Decrease in Stocks | 90.77 | -29.14 | -57.57 |
| Employees Cost | 139.75 | 116.65 | 143.85 |
| Depreciation | 59.95 | 50.70 | 38.67 |
| Other Expenses | 86.86 | 100.10 | 69.21 |
| Total Expenses | 740.79 | 677.00 | 586.09 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 349.45 | 304.00 | 277.47 |
| Other Income | 71.04 | 38.43 | 47.30 |
| P/L Before Interest, Excpt. Items & Tax | 420.49 | 342.43 | 324.77 |
| Interest | 4.64 | 3.07 | 7.26 |
| P/L Before Exceptional Items & Tax | 415.85 | 339.36 | 317.51 |
| P/L Before Tax | 415.85 | 339.36 | 317.51 |
| Tax | 106.63 | 132.41 | 73.20 |
| P/L After Tax from Ordinary Activities | 309.22 | 206.95 | 244.31 |
| Net Profit/Loss For the Period | 309.22 | 206.95 | 244.31 |
| Net P/L After Minority Interest & Share Of Associates | 309.22 | 206.95 | 244.31 |
| | | | |
| Equity Share Capital | 112.32 | 111.82 | 111.82 |
| Reserves And Surplus | 0.00 | 2298.05 | 0.00 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 5.51 | 3.70 | 4.37 |
| Diluted EPS (Rs.) | 27.53 | 9.25 | 4.29 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 5.51 | 3.70 | 4.37 |
| Diluted EPS (Rs.) | 13.77 | 9.25 | 4.29 |
| | | | |
| PBITOE Margin (%) | 32.05 | 30.98 | 32.13 |
| PBTE Margin (%) | 38.14 | 34.59 | 36.76 |
| PBT Margin (%) | 38.14 | 34.59 | 36.76 |
| PAT Margin (%) | 28.36 | 21.09 | 28.29 |
| PAT After MI And SOA Margin (%) | 28.36 | 21.09 | 28.29 |
